https://openbell.ai/ 2026-09-30T09:59:51.156Z hourly 1.0 https://openbell.ai/support 2026-09-30T09:59:51.156Z monthly 0.7 https://openbell.ai/privacy 2026-09-30T09:59:51.156Z monthly 0.5 https://openbell.ai/terms 2026-09-30T09:59:51.156Z monthly 0.5 https://openbell.ai/feed.json 2026-09-30T09:59:51.156Z hourly 0.8 https://openbell.ai/news/ABBV:1790762236755 2026-09-30T09:57:16.755Z daily 0.9 https://cdn.brandfetch.io/ABBV/w/400/h/400?c=1idopYfmtR7ZKg8QMud Abbvie Shared Detailed Results From The Multiple Ascending Dose Part Of Its Phase 1 Study Evaluating ABBV-295 At EASD Annual Meeting, Showing Favorable Tolerability And Pharmacokinetic Profile AbbVie (NYSE: ABBV) presented detailed results from the multiple ascending dose part of its Phase 1 study evaluating ABBV-295 at the EASD Annual Meeting. The study involved 60 participants and showed that ABBV-295 resulted in meaningful weight loss, with reductions ranging from -7.8% to -9.8% over 12-13 weeks, compared to approximately -0.3% for placebo. The pharmacokinetic profile supports dosing intervals beyond weekly administration, and gastrointestinal adverse events were predominantly mild. AbbVie plans to advance ABBV-295 into Phase 2 development. https://openbell.ai/news/AYTU:1790762201912 2026-09-30T09:56:41.912Z daily 0.9 https://cdn.brandfetch.io/AYTU/w/400/h/400?c=1idopYfmtR7ZKg8QMud Ascendiant Capital Maintains Buy on Aytu BioPharma, Raises Price Target to $15 Ascendiant Capital analyst Edward Woo has maintained a Buy rating on Aytu BioPharma (NASDAQ: AYTU) and raised the price target from $14.5 to $15. This adjustment reflects a positive outlook for the company. https://openbell.ai/news/ORBS:1790762025298 2026-09-30T09:53:45.298Z daily 0.9 https://cdn.brandfetch.io/ORBS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Sam Altman-Linked World Token Rallies 35% in a Month, Leaving BTC, DOGE Behind — Here's Why AI Agents Could Be Fueling the Surge The World (WLD) token has surged 35% over the past month, reaching a peak of $0.58, its highest level since June, and is currently valued at nearly $2 billion. This performance has outpaced major cryptocurrencies like Bitcoin, Ethereum, and Dogecoin. The token's growth is attributed to the increasing demand for AI agents and its unique identity verification approach. Additionally, shares of Eightco Holdings Inc., the largest institutional holder of WLD, have risen nearly 47% in the same period. https://openbell.ai/news/LEVI:1790761999680 2026-09-30T09:53:19.680Z daily 0.9 https://cdn.brandfetch.io/LEVI/w/400/h/400?c=1idopYfmtR7ZKg8QMud BTIG Reiterates Buy on Levi Strauss, Maintains $27 Price Target BTIG analyst Robert Drbul has reiterated a Buy rating on Levi Strauss (NYSE: LEVI) and maintained a price target of $27 for the stock. This endorsement reflects confidence in the company's performance and market position. https://openbell.ai/news/KKR:1790761733213 2026-09-30T09:48:53.213Z daily 0.9 https://cdn.brandfetch.io/KKR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Bloomberg Reported Japan’S Toho Eyes KKR’S Health Device Maker PHC For $1.3B Toho, a Japanese company, is reportedly interested in acquiring PHC, a health device maker owned by KKR, for approximately $1.3 billion. This potential acquisition reflects Toho's strategy to expand its presence in the health technology sector. The deal, if finalized, could have significant implications for both companies and the broader health device market. https://openbell.ai/news/SSTI:1790761500206 2026-09-30T09:45:00.206Z daily 0.9 https://cdn.brandfetch.io/SSTI/w/400/h/400?c=1idopYfmtR7ZKg8QMud Roth Capital Downgrades SoundThinking to Neutral, Announces $9 Price Target Roth Capital analyst Richard Baldry has downgraded SoundThinking (NASDAQ: SSTI) from a 'Buy' rating to 'Neutral.' The firm has set a new price target of $9 for the stock. https://openbell.ai/news/MU:1790761406147 2026-09-30T09:43:26.147Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/30/Micron-Technology-Logo-On-Circuit-Board.jpg?width=250&height=187 Micron’s AI Boom Isn’t Done yet, Analysts Say — but Can the Stock Keep Exploding Higher? Micron Technology Inc. (NASDAQ: MU) is set to report its fiscal fourth-quarter results on September 30, with analysts expecting earnings per share (EPS) of $31.45 and revenue of $50.75 billion, a significant increase from $3.03 EPS and $11.31 billion in the prior year. JPMorgan projects a potential revenue beat, anticipating DRAM prices to rise over 20% sequentially, while Bank of America emphasizes the importance of sustaining gross margins in the mid-80% range through fiscal 2027. The stock was trading at $1,072.90, reflecting a 0.79% increase in premarket trading, with an average price forecast of $1,541.09 among analysts. https://openbell.ai/news/YRD:1790761172046 2026-09-30T09:39:32.046Z daily 0.9 https://cdn.brandfetch.io/YRD/w/400/h/400?c=1idopYfmtR7ZKg8QMud Yiren Digital Q2 EPS $(0.75) Down From $0.57 YoY, Sales $131.167M Down From $230.624M YoY Yiren Digital (NYSE:YRD) reported a Q2 loss of $(0.75) per share, a significant decline of 231.58% compared to earnings of $0.57 per share from the previous year. The company's sales totaled $131.167 million, reflecting a 43.13% decrease from $230.624 million in the same quarter last year. https://openbell.ai/news/ACHV:1790760865032 2026-09-30T09:34:25.032Z daily 0.9 https://cdn.brandfetch.io/ACHV/w/400/h/400?c=1idopYfmtR7ZKg8QMud Stifel Initiates Coverage On Achieve Life Sciences with Buy Rating, Announces Price Target of $18 Stifel analyst James Condulis has initiated coverage on Achieve Life Sciences (NASDAQ: ACHV) with a Buy rating. The firm has set a price target of $18 for the company's stock. https://openbell.ai/news/FNGR:1790760776791 2026-09-30T09:32:56.791Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/30/The-Real-Villains-No-Longer-Hide.jpg?width=250&height=187 Why FingerMotion Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket FingerMotion Inc (NASDAQ: FNGR) shares increased by 18.1% to $0.16 in pre-market trading following the announcement of a definitive Share Purchase Agreement to acquire 100% of Newbit Technology Inc. for $2.3 million in cash, on a cash-free, debt-free basis. This acquisition marks a strategic move for FingerMotion as it seeks to expand its business operations. https://openbell.ai/news/GILD:1790760382262 2026-09-30T09:26:22.262Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/30/Former-President-Bill-Clinton-at-an-even.jpg?width=250&height=187 Bill Clinton Sounds Alarm on HIV Funding: ‘Cheaper Medicines Mean Nothing If They Never Reach People’ Former President Bill Clinton expressed concerns over potential disruptions to HIV treatment and prevention programs due to abrupt changes in funding. He emphasized that while lowering the cost of HIV medicines is important, accessibility is crucial, stating, "Cheaper medicines mean nothing if they never reach people." Clinton warned against reversing progress for political reasons, highlighting the human cost of such actions. Additionally, Gilead Sciences recently received FDA approval for its single-tablet HIV treatment, Bixlenvo, which maintains viral suppression. https://openbell.ai/news/FORM:1790759952532 2026-09-30T09:19:12.532Z daily 0.9 https://cdn.brandfetch.io/FORM/w/400/h/400?c=1idopYfmtR7ZKg8QMud Deutsche Bank Initiates Coverage On FormFactor with Buy Rating, Announces Price Target of $200 Deutsche Bank analyst George Brown has initiated coverage on FormFactor (NASDAQ: FORM) with a Buy rating. The bank has set a price target of $200 for the company's stock. https://openbell.ai/news/MSFT:1790759252385 2026-09-30T09:07:32.385Z daily 0.9 https://cdn.brandfetch.io/MSFT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Piper Sandler Maintains Overweight on Microsoft, Raises Price Target to $610 Piper Sandler analyst Billy Fitzsimmons has maintained an Overweight rating on Microsoft (NASDAQ: MSFT) and increased the price target from $550 to $610. This adjustment reflects a positive outlook on the company's performance. https://openbell.ai/news/AMPL:1790759124595 2026-09-30T09:05:24.595Z daily 0.9 https://cdn.brandfetch.io/AMPL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Piper Sandler Maintains Overweight on Amplitude, Raises Price Target to $18 Piper Sandler analyst Billy Fitzsimmons has maintained an Overweight rating on Amplitude (NASDAQ: AMPL) and increased the price target from $13 to $18. This adjustment reflects a positive outlook on the company's performance. https://openbell.ai/news/MU:1790756977364 2026-09-30T08:29:37.364Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/30/Micron-MU-Logo-On-Smartphone-With-Semico.jpg?width=250&height=187 MU Stock Split Chatter Divides Traders Online Ahead of Earnings: 'Would It Make Sense' or Get 'Annihilated'? Micron Technology Inc. (NASDAQ: MU) shares are trading above $1,000 ahead of its fiscal fourth-quarter earnings report, with analysts expecting record revenue of $51.13 billion and earnings per share of $31.50. Retail traders are speculating about a potential stock split, with discussions of a 10-for-1 split and price targets ranging from $1,500 to $2,500 per share. The stock has gained 237.67% this year and 536.55% over the past year, closing at $1,065.08, up 1.05% on Tuesday. https://openbell.ai/news/UCO:1790756738222 2026-09-30T08:25:38.222Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/30/Former-President-Donald-J--Trump-Arrives.jpg?width=250&height=187 Trump Offers 40M Barrels From US Oil Reserve — But Buyers Aren’t Biting: Global Refining Capacity Is The Problem, Says Top Oil Analyst The Trump administration's plan to offer 40 million barrels of oil from the Strategic Petroleum Reserve (SPR) is facing low interest from buyers, primarily due to global refining capacity issues, according to GasBuddy analyst Patrick De Haan. The Department of Energy's request for proposal is part of a larger 172-million-barrel release announced in March. As of September 18, 284 million barrels remain in the SPR, while WTI crude futures have slightly declined to $89.30. The national average gas price has decreased to $4.4558 per gallon. https://openbell.ai/news/F:1790756737316 2026-09-30T08:25:37.316Z daily 0.9 https://cdn.brandfetch.io/F/w/400/h/400?c=1idopYfmtR7ZKg8QMud Ford Recalls 41,748 Expedition, F-250 SD, F-350 SD, F-450 SD And F-550 SD Vehicles Over Contaminated Headlight LED Chip Risking Lighting Loss Ford is recalling 41,748 vehicles, including the Expedition and various F-Series Super Duty models (F-250, F-350, F-450, and F-550), due to a risk of lighting loss caused by contaminated headlight LED chips. The recall is being overseen by the National Highway Traffic Safety Administration. This action may impact Ford's reputation and potentially its stock performance. https://openbell.ai/news/SNOW:1790756550919 2026-09-30T08:22:30.919Z daily 0.9 https://cdn.brandfetch.io/SNOW/w/400/h/400?c=1idopYfmtR7ZKg8QMud Snowflake And LSEG Announce Expanded Five-Year Enterprise-Wide Collaboration To Deliver Governed AI With Trusted Financial Data For Regulated Markets Snowflake and LSEG have announced a five-year expansion of their collaboration to enhance access to trusted financial data for regulated markets. This partnership will strengthen LSEG's use of Snowflake's AI Data Cloud across various functions, including data analytics and reporting. The initiative aims to create a secure and governed infrastructure for organizations to implement AI effectively. https://openbell.ai/news/XOM:1790755979433 2026-09-30T08:12:59.433Z daily 0.9 https://cdn.brandfetch.io/XOM/w/400/h/400?c=1idopYfmtR7ZKg8QMud Petrovietnam Unit BSR Signs ExxonMobil Asia-Pacific Crude Supply Agreement Ensuring Minimum 2M Barrels Yearly For Dung Quat Refinery, Alongside Chevron Framework Pact Petrovietnam's subsidiary, BSR, has signed a supply agreement with ExxonMobil to secure a minimum of 2 million barrels of crude oil annually for the Dung Quat Refinery. Additionally, BSR has entered into a framework agreement with Chevron. These agreements aim to enhance energy cooperation between Vietnam and the US. https://openbell.ai/news/DASH:1790755590282 2026-09-30T08:06:30.282Z daily 0.9 https://cdn.brandfetch.io/DASH/w/400/h/400?c=1idopYfmtR7ZKg8QMud DoorDash Expands India Footprint With Hyderabad Global Tech Hub, Adding To Pune Office, And Plans 3,000 Jobs DoorDash is expanding its presence in India by establishing a global tech hub in Hyderabad and enhancing its office in Pune. The company plans to create 3,000 new jobs as part of this expansion. This move indicates DoorDash's commitment to growing its operations in the Indian market. https://openbell.ai/news/FIS:1790755327418 2026-09-30T08:02:07.418Z daily 0.9 https://cdn.brandfetch.io/FIS/w/400/h/400?c=1idopYfmtR7ZKg8QMud FIS Wins Norwegian Consumer Credit Institution Kredittbanken As PRIME In The Cloud Client To Support Growth Across Network Of 69 Savings Banks openbell Financial News https://openbell.ai/news/AMTM:1790755215814 2026-09-30T08:00:15.814Z daily 0.9 https://cdn.brandfetch.io/AMTM/w/400/h/400?c=1idopYfmtR7ZKg8QMud Amentum Joint Venture Selected As Preferred Supplier By Sellafield Ltd For Up To $2.78B Asset Care And Asset Creation Program openbell Financial News https://openbell.ai/news/EWG:1790755051048 2026-09-30T07:57:31.048Z daily 0.9 https://cdn.brandfetch.io/EWG/w/400/h/400?c=1idopYfmtR7ZKg8QMud Germany Unemployment Change For September 12K Vs. 1K Est.; 4K Prior openbell Financial News https://openbell.ai/news/DBVT:1790754187768 2026-09-30T07:43:07.768Z daily 0.9 https://cdn.brandfetch.io/DBVT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Reported Earlier, DBV Technologies Submits BLA To FDA For VIASKIN Peanut Patch In Children Aged 4-7 With Peanut Allergy, Requests Priority Review DBV Technologies has submitted a Biologics License Application (BLA) to the U.S. FDA for the VIASKIN Peanut Patch aimed at children aged 4-7 with peanut allergies. This application is backed by results from the Phase 3 VITESSE trial, which is noted as the largest immunotherapy clinical trial for this demographic. The company has also requested Priority Review for the BLA. https://openbell.ai/news/BA:1790754150292 2026-09-30T07:42:30.292Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/30/Boeing.jpg?width=250&height=187 BA Stock Climbs After Boeing Secures $20 Billion Contract as Pentagon Pushes Next-Generation Carrier Fighter Program After Years of Delays Boeing Co. has secured a contract exceeding $20 billion to develop the U.S. Navy's F/A-XX next-generation stealth fighter, marking its second major sixth-generation fighter program win in two years. This contract comes as the Pentagon aims to enhance U.S. air-combat capabilities, with the F/A-XX expected to replace the Navy's F/A-18E/F Super Hornets and EA-18G Growlers in the 2030s. Following the announcement, Boeing's stock rose 2.20% to $191.81 in after-hours trading, while Northrop Grumman's shares fell 2.65% to $491.23. https://openbell.ai/news/HII:1790754094686 2026-09-30T07:41:34.686Z daily 0.9 https://cdn.brandfetch.io/HII/w/400/h/400?c=1idopYfmtR7ZKg8QMud Reported Earlier, HII Lands U.S. Navy Contract For 10 ROMULUS USVs Under MUSV Program, Building On 2025 Production Commitments openbell Financial News https://openbell.ai/news/SMA:1790754012984 2026-09-30T07:40:12.984Z daily 0.9 https://cdn.brandfetch.io/SMA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Reported Earlier, SmartStop To Take Over Property Management From Bluebird As Part Of Proposed Canadian Self-Storage Joint Venture Backed By Up To $300M openbell Financial News https://openbell.ai/news/BTCUSD:1790753979682 2026-09-30T07:39:39.682Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/30/Bitcoin-Btc-Virtual-Cryptocurrency-In-Fr.jpg?width=250&height=187 Bitcoin Demand Showing 'Signs of Improvement' Despite 'Challenging' Backdrop, Says Binance Co-CEO as Spot ETF Inflows Surge Binance Co-CEO Richard Teng reported that institutional demand for Bitcoin is improving despite a challenging macroeconomic environment, with spot Bitcoin ETFs recording over $3 billion in net inflows from September 17 to September 29. The week ending September 25 saw the strongest inflows since last October, totaling $2.4 billion, and year-to-date inflows have surpassed $1 billion. Bitcoin has risen 43% in the third quarter, marking its best quarterly performance since late 2024. https://openbell.ai/news/VNDA:1790753829666 2026-09-30T07:37:09.666Z daily 0.9 https://cdn.brandfetch.io/VNDA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Reported Earlier, Vanda Says Phase III HETLIOZ Study Met Primary Endpoint In Delayed Sleep-Wake Phase Disorder, Shifting Sleep Onset 37.1 Minutes Earlier Versus Placebo; sNDA Planned openbell Financial News https://openbell.ai/news/ACCV:1790753777345 2026-09-30T07:36:17.345Z daily 0.9 https://cdn.brandfetch.io/ACCV/w/400/h/400?c=1idopYfmtR7ZKg8QMud Reported Earlier, Accelevation Prices Initial Public Offering Of 30M Class A Shares At $18.00 Per Share, Including 10M From Company And 20M From Olympus-Affiliated Selling Stockholders openbell Financial News https://openbell.ai/news/NAMM:1790752842160 2026-09-30T07:20:42.160Z daily 0.9 https://cdn.brandfetch.io/NAMM/w/400/h/400?c=1idopYfmtR7ZKg8QMud Reported Earlier, Namib Minerals Locks In $6.5M Non-Dilutive BancABC Term Loan To Keep Redwing Mine Restart On Milestone Schedule, Partially Funding Step 3 openbell Financial News https://openbell.ai/news/FFAI:1790752408197 2026-09-30T07:13:28.197Z daily 0.9 https://cdn.brandfetch.io/FFAI/w/400/h/400?c=1idopYfmtR7ZKg8QMud Reported Earlier, Faraday Future Unveils Phase Two Of "Built In USA" Program, Targets Robot Factory By Year-End, First New Robot Product In Q1 2027 Faraday Future (FF) has announced phase two of its 'Built in USA' program, aiming to launch a new robot factory by year-end and produce its first EAI robot product by Q1 2027. The company has signed a term sheet with Nasdaq-listed AIxC to bring 100% of its robotics division into AIxC, valuing the transaction at approximately $200 million. Additionally, a potential special stock dividend of $2.246 per share is proposed, which would benefit existing stockholders at no extra cost, with an illustrative value of about $55 million on a fully diluted basis. https://openbell.ai/news/PYXS:1790751405267 2026-09-30T06:56:45.267Z daily 0.9 https://cdn.brandfetch.io/PYXS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Pyxis Oncology Prices $110M Offering Of 36,047,919 Shares At $2.90 With Common Warrants For 49,310,352 Shares At $3.50 Exercise Price openbell Financial News https://openbell.ai/news/ABBV:1790751274338 2026-09-30T06:54:34.338Z daily 0.9 https://cdn.brandfetch.io/ABBV/w/400/h/400?c=1idopYfmtR7ZKg8QMud AbbVie Says All Three Zumilokibart Dose Regimens Met Primary Endpoint With Significantly Greater EASI-75 Response Vs Placebo At Week 16 In Phase 2 APEX Part B Atopic Dermatitis Study AbbVie announced that all three dose regimens of its drug zumilokibart met the primary endpoint in a Phase 2 study for atopic dermatitis, showing significantly greater EASI-75 response rates compared to placebo at Week 16. The mid-dose regimen has been selected for Phase 3 development to further evaluate its efficacy, safety, and dosing profile. Zumilokibart is a half-life extended monoclonal antibody targeting IL-13. https://openbell.ai/news/TAK:1790751153079 2026-09-30T06:52:33.079Z daily 0.9 https://cdn.brandfetch.io/TAK/w/400/h/400?c=1idopYfmtR7ZKg8QMud Takeda Presents Phase 3 Data Showing Once-Daily Oral Zasocitinib Delivers Higher PASI 100 At 36.5% Vs 13.9% And PASI 90 At 62.5% Vs 34.0% Than Deucravacitinib At Week 16; Under FDA, EMA Review For Plaque Psoriasis Takeda's Phase 3 data for oral zasocitinib shows it achieved a PASI 100 rate of 36.5% and PASI 90 rate of 62.5% at week 16, significantly outperforming deucravacitinib, which had rates of 13.9% and 34.0%, respectively. The LATITUDE Atlas study indicated that zasocitinib demonstrated statistical superiority across primary and secondary efficacy endpoints, with complete skin clearance observed as early as week 8. The findings are currently under review by the FDA and EMA for the treatment of plaque psoriasis. https://openbell.ai/news/RHHBY:1790750593392 2026-09-30T06:43:13.392Z daily 0.9 https://cdn.brandfetch.io/RHHBY/w/400/h/400?c=1idopYfmtR7ZKg8QMud FDA Accepts Roche's Fenebrutinib NDA Under Priority Review For Relapsing And Primary Progressive MS, Backed By Phase III Data Showing 51.1%, 58.5% Relapse Reductions Vs Teriflunomide The FDA has accepted Roche's New Drug Application (NDA) for fenebrutinib under priority review for treating relapsing and primary progressive multiple sclerosis (MS), supported by Phase III trial data showing a 51.1% and 58.5% reduction in relapses compared to teriflunomide. Fenebrutinib is notable for being the first investigational medicine in over a decade to demonstrate a slowing of disability progression in a Phase III trial for primary progressive MS. If approved, it would be the first BTK inhibitor and high-efficacy oral treatment for both relapsing and primary progressive MS, potentially benefiting nearly 1 million Americans with the condition. https://openbell.ai/news/RDW:1790750412391 2026-09-30T06:40:12.391Z daily 0.9 https://cdn.brandfetch.io/RDW/w/400/h/400?c=1idopYfmtR7ZKg8QMud Redwire Teams Up With Sophia Space To Pair Deployable Systems And Integration Expertise With TILE Architecture For Scalable Orbital Data Centers Redwire has signed a Memorandum of Understanding (MOU) with Sophia Space to collaborate on deployable structures and spacecraft integration. The partnership aims to develop scalable architectures for in-orbit Artificial Intelligence and edge computing, leveraging Redwire's TILE architecture. This strategic alliance is expected to enhance Redwire's capabilities in the growing market for orbital data centers. https://openbell.ai/news/FNGR:1790748660837 2026-09-30T06:11:00.837Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/30/Stock-Market-Trading-Chart-And-Analyzing.jpg?width=250&height=187 FingerMotion (FNGR) Stock Jumps 34% After Hours: What's Going On FingerMotion, Inc. (NASDAQ: FNGR) shares surged 34.35% to $0.18 in after-hours trading following the announcement of a definitive Share Purchase Agreement to acquire 100% of Newbit Technology Inc for $2.3 million in cash. The acquisition includes rights and infrastructure for a 9.9 MW behind-the-meter site in Alberta. Despite this increase, FingerMotion's stock has fallen 91.28% over the past year, with a market capitalization of approximately $10.60 million. https://openbell.ai/news/MU:1790748301537 2026-09-30T06:05:01.537Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/30/Market-sentiment---Fear-and-Greed.jpg?width=250&height=187 Dow Falls Over 100 Points as Treasury Yields Rise: Investor Sentiment Weakens, Fear & Greed Index Stays in ‘Fear’ Zone On Tuesday, the Dow Jones index fell over 132 points to close at 51,349.92, driven by rising Treasury yields and a decline in investor sentiment, as indicated by the CNN Money Fear and Greed index, which remained in the 'Fear' zone with a reading of 32. U.S. job openings decreased by 256,000 to 7.079 million in August, below market expectations. Meanwhile, Carnival Corporation reported better-than-expected third-quarter results and raised its FY26 adjusted EPS guidance above estimates. https://openbell.ai/news/DAL:1790746470466 2026-09-30T05:34:30.466Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/30/Paris--France---June-16--2023-Elon-Musk-.jpg?width=250&height=187 Elon Musk Doubles Down on Delta, Says CEO Ed Bastian Will ‘Lose His Job’ Over Starlink Snub Elon Musk, CEO of SpaceX, criticized Delta Air Lines CEO Ed Bastian for not choosing Starlink for in-flight internet service, suggesting Bastian could lose his job over this decision. Delta has opted for Amazon's LEO satellite internet service instead, planning to roll it out on over 500 aircraft starting in 2028. Musk warned that Delta risks losing customers to competitors like United Airlines and Alaska Air, which are adopting Starlink connectivity. https://openbell.ai/news/FXI:1790745710001 2026-09-30T05:21:50.001Z daily 0.9 https://cdn.brandfetch.io/FXI/w/400/h/400?c=1idopYfmtR7ZKg8QMud Reported Earlier, China Composite Purchasing Managers' Index For September 50.7 Vs. 49.5 Prior openbell Financial News https://openbell.ai/news/KALA:1790745475753 2026-09-30T05:17:55.753Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/30/A-Dynamic-Blue-Arrow-Superimposed-On-A-S.jpg?width=250&height=187 KALA Bio (KALA) Shares Soar 57% After Hours: Here's Why Kala Bio Inc. (NASDAQ: KALA) shares surged 57.10% to $0.79 in after-hours trading following the announcement of a non-binding letter of intent to acquire a telehealth platform valued at approximately $15 million. The target platform, which generated about $12.7 million in revenue over the past twelve months and is cash-flow positive, has served over 90,000 clients since its founding in 2023. KALA Bio's market capitalization stands at approximately $9.74 million, although its shares have declined 99.34% over the past year. https://openbell.ai/news/EWA:1790745318717 2026-09-30T05:15:18.717Z daily 0.9 https://cdn.brandfetch.io/EWA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Reported Earlier, Australia Building Approvals (MoM) Preliminary For August -6.1% Vs. -2.0% Est.; -1.9% (Revised) Prior openbell Financial News https://openbell.ai/news/SPY:1790745255362 2026-09-30T05:14:15.362Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/30/Stock-S-And-P-500-Index-Fund-Symbol-Is-O.jpg?width=250&height=187 Stock Market: Will S&P 500 Open Up or Down Today? U.S. stock futures are trending higher, with the S&P 500 futures up 0.24%, as traders anticipate a positive open on September 30, reflecting a 72% chance according to Polymarket. Key economic reports, including the ADP national employment report and PCE price index data, are set for release, alongside earnings from companies like Micron Technology and Jabil Inc. The market is also reacting to geopolitical developments, including U.S. troop withdrawals from Iraq and stabilizing oil prices, with Brent crude at $96.40 per barrel. https://openbell.ai/news/EWJ:1790745235181 2026-09-30T05:13:55.181Z daily 0.9 https://cdn.brandfetch.io/EWJ/w/400/h/400?c=1idopYfmtR7ZKg8QMud Reported Earlier, Japan Industrial Production (MoM) Preliminary For August -1.7% Vs. 1.4% Est.; -0.2% Prior openbell Financial News https://openbell.ai/news/BTCUSD:1790742423282 2026-09-30T04:27:03.282Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/30/Solana-Golden-Cryptocurrency-In-Close-up.jpg?width=250&height=187 Tom Lee Asks Investors, 'Do You Have Enough Crypto,' After Changpeng Zhao Hints Bull Market Could Come 'Soon' Bitmine Immersion Technologies Inc. (NYSE: BMNR) Chair Tom Lee and Binance founder Changpeng Zhao have expressed optimism about a potential bull market in cryptocurrencies. Lee maintains a $150,000 target for Bitcoin and $60,000 for Ethereum in the coming years, while Bitmine recently purchased 17,362 ETH, increasing its total holdings to over 6 million ETH valued at more than $16 billion. Despite a recent decline in major cryptocurrencies, Bitmine shares fell only slightly by 0.41% to close at $26.73. https://openbell.ai/news/HOOD:1790738264983 2026-09-30T03:17:44.983Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/30/Robinhood-Robinhood-Mobile-Icon-App-On-A.jpg?width=250&height=187 Robinhood Bets on AI Agents That Can Trade While You Sleep: Vlad Tenev Says Gave Traders 'Tools' Reserved for Hedge Funds and Big Banks Robinhood Markets Inc. (NASDAQ: HOOD) has launched new AI trading tools, including autonomous trading agents that operate within the app, aimed at democratizing trading strategies previously available only to hedge funds and banks. Since May, over 150,000 customers have opened accounts utilizing these AI agents, which perform approximately 30 million data pulls daily. Following the announcement, Robinhood's stock rose by 2.11% in after-hours trading, closing at $118.71. The company is also introducing a subscription marketplace for premium market data and plans to enable continuous trading through AI agents. https://openbell.ai/news/NVDA:1790736564176 2026-09-30T02:49:24.176Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/30/Cathie-Wood-Doubles-Down-On-Bitcoin-ETF-.jpg?width=250&height=187 Cathie Wood Goes Big on Nvidia After $150 Billion Buyback, Sells $110 Million of AMD: ARK Invest Also Picks Up Tesla, SpaceX Shares Cathie Wood's Ark Invest made significant trades on Tuesday, acquiring 356,681 shares of NVIDIA Corporation (NASDAQ: NVDA) for approximately $81 million following NVIDIA's announcement of a $150 billion stock buyback. Additionally, Ark Invest purchased 48,352 shares of Tesla Inc (NASDAQ: TSLA) valued at around $17.1 million and increased its stake in Broadcom Inc (NASDAQ: AVGO) with an investment of approximately $27.1 million. Conversely, Ark sold 181,767 shares of Advanced Micro Devices, Inc. (NASDAQ: AMD) for about $110.4 million. https://openbell.ai/news/META:1790734337555 2026-09-30T02:12:17.555Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/30/Washington-D-c---Usa---April-7--2025-Uni.jpg?width=250&height=187 Mark Zuckerberg Labels It 'Significant Positive Step,' Musk Nods Yes as Trump Inks New AI Safety Deal With Top CEOs President Donald Trump announced a voluntary safety pact for AI companies, called the White House Accord on Super Intelligence, which was signed by leaders from major firms including Alphabet, Meta, and OpenAI. The agreement mandates independent audits, stronger internal controls, and board-level oversight for AI systems. Mark Zuckerberg described the accord as a 'significant positive step' towards enhancing public confidence in AI technology. The pact also suggests the potential for future regulation of AI safety standards. https://openbell.ai/news/TSLA:1790733910175 2026-09-30T02:05:10.175Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/30/Optimus-Faces-Technical-Hurdles.jpg?width=250&height=187 Tesla Locks in $30 Billion in New Credit as It Scales Up Optimus, Cybercab and Joint Solar Plans With SpaceX Tesla Inc. has secured $30 billion in new credit facilities to support its investments in AI and production of Cybercab robotaxis and Optimus robots. The credit package includes a $20 billion term loan from Citibank, an $8 billion revolving credit facility, and a $2 billion short-term facility led by Wells Fargo. CEO Elon Musk announced plans for Tesla and SpaceX to jointly produce 200 gigawatts of solar power annually, while the company anticipates over $25 billion in capital expenditures this year. Following the announcement, Tesla's stock fell 1.29% to $352.84.